Análise de custo-efetividade de medicamentos na área de medicina sexual ofertados pelo SUS em hospital terciário

Abstract

Introduction: Despite the existence of several access to medication programs within the SUS, most prescribing professionals are unaware of these programs. In view of this context, many times patients seek the judicial sector to acquire medications for their treatment. None of the medications considered essential for the treatment of some health problems in men, such as Sexual Dysfunction, especially Erectile Dysfunction (ED), were observed in the Rename. Objective: The aim of this study was to analyze the cost-effectiveness of medications in the area of Sexual Medicine provided by SUS in a tertiary hospital, taking into account: medical prescriptions offered to users in outpatient care, prescriptions for medications not available at SUS and judicialization of available and not available medications at SUS. Casuistics and Methods: Retrospectively, the cost-effectiveness of medications offered by SUS to patients admitted to a tertiary care hospital in São José do Rio Preto, SP, from January 2016 to December 2020 was investigated. Prescriptions with the following medications: testosterone cypionate, testosterone undecanoate, testosterone undecylate, sildenafil, tadalafil and alprostadil, have been offered to the SUS users. Results: There were 7,929 medical appointments at the Urology/Men's Health Outpatient Clinic. Also, 5,020 prescriptions were offered and 1,377 prescriptions of specific medications for the treatment of ED. It is noteworthy that all prescriptions offered to users were for medications not available at SUS. Conclusions: According to the proposed objectives, it was observed that the medications in the area of Sexual Medicine, within the SUS, even not being available in any of the pharmaceutical assistance programs; presented a low rate of access through judicial means. However, these were offered and acquired in a cost-effective way